Biogen

European stocks reach six-week highs as Nestlé shines

Strong results from Swiss group boost food stocks, offsetting losses elsewhere

Drug company Perrigo welcomes settlement of record tax bill

Company will pay over money within seven days of formal agreement being signed

Perrigo agrees €300m settlement of €1.64bn tax assessment

Tax dispute dates back to a 2016 audit by Revenue

Moody’s says Perrigo acquisition adds to Irish tax concerns

Ratings agency turns negative on outlook for ‘over-the-counter’ medicines group over potential debt burden

Dovish ECB and upbeat earnings support euro-zone stocks

ECB pledges to keep interest rates at record lows for even longer

Perrigo boss on the largest tax bill ever issued by Revenue

Business interview: CEO Murray Kessler talks Covid and sorting out Perrigo’s Irish tax bill

Ireland's largest tax bill falls 40% to €976m

Revenue Commissioners and Perrigo have been in intense discussions for months

Like Caesar’s wife, FDA must be above suspicion

Fallout from controversial approval of Alzheimer’s drug is a concern

Europe should approach new Alzheimer’s drug with care

A decision by the US FDA to approve aducanumab has alarmed many experts

Shares buoyed by hopes ECB will keep bond-buying scheme in place

Bank shares suffer as bond yields tighten

Stocks hover close to record highs on good day for airlines

Market edgy ahead of ECB policy decision and US inflation data

Is Biogen’s new Alzheimer’s drug a breakthrough or false hope?

Medical community sharply divided on the benefits of this drug in treating dementia

Biogen will charge $56,000-a-year for Alzheimer’s drug

Price over double the highest industry analyst estimate triggers renewed criticism

US regulators approve Alzheimer’s drug from Biogen

Many scientists opposed approval of controversial treatment, saying it did not work

Revenue rejects settlement offer on €1.64bn Perrigo tax bill

Consumer healthcare group hit with largest tax assessment ever issued by commissioners

Perrigo makes offer to Revenue on disputed €1.64bn tax bill

Amount is second-largest in the history of the State, behind only high-profile Apple case

Limerick-based software company Kneat secures €14.9m in financing

Irish-founded firm is listed on Toronto Stock Exchange but is run from Limerick

Warren Buffett pulls back on banks and bets on drug makers

Billionaire investor’s Berkshire Hathaway sinks $5.7bn into four US pharma stocks

Nikkei closes at near three-decade high as Biden edges closer to win

Investors hope a gridlock in US congress would be able to stall major policy changes

Biogen shares leap after ‘substantial evidence’ Alzheimer’s drug is effective

Aducanumab targets clumps of protein that can build up in the brain

Perrigo loses action to overturn €1.64bn Irish tax assessment

Action brought by drug firm against Revenue closely watched for implications beyond case

Perrigo mulls over appeal path to pursue on €1.64bn tax bill

US pharma giant says it is disappointed by High Court judgment

High Court to rule on €1.64bn Perrigo tax case next week

Judgment could have major implications well beyond the drug company

Perrigo plans €840m Irish restructuring of old Elan unit to pay dividend

US-based drugs giant plans to reconfigure its share capital to create a distributable reserve

Pharma lobby group appoints Paul Reid as president

Irish Pharmaceutical Healthcare Association seeks State accord on access to new therapies

European stocks end week with gains for tech and telecoms

Dublin market closed marginally higher with food stocks leading the way

Apple loses €56 million of funds held in escrow as Lidl increases headcount

Seen and Heard: Funds chase Perrigo over Irish tax, hotels down €200m on weddings

A new Irish unicorn: Irish software firm Workhuman latest to be valued at over $1bn

Tech firm thought to be only the second Irish company to confirm it has hit $1bn valuation mark

European shares end lower on fears of ‘second wave’ of Covid-19

Stoxx 600 weighed down by Wirecard over missing $2.1bn in payments firm’s accounts

Revenue says Perrigo is no ‘sacrificial victim’ over €1.6bn tax bill

Drug company not being ‘singled out’ in dispute over tax assessment, High Court told

Revenue tells court it was entitled to raise €1.64bn tax assessment against Perrigo

Tax collector maintains Perrigo owes the money because of its 2013 purchase of Elan

Perrigo tells court of ‘very high level of unfairness’ in €1.64bn tax bill

Pharma group challenging ‘surprise’ Revenue assessment in hearing via video link

Perrigo’s High Court challenge to €1.64bn tax bill to be heard remotely

US drug company case to be heard via video link due to Covid-19 courtroom restrictions

Revenue faces US drug company Perrigo over disputed €1.64bn tax bill

Irish tax authorities argue sale of drug for MS should have been treated as capital gain

Irish staff of firm at centre of US coronavirus outbreak sent home

Massachusetts has reported 70 cases linked to company’s Boston conference last month

Perrigo has ‘better than 50% chance’ of winning Irish tax case

US analyst RBC upbeat about High Court challenge to €1.64bn charge over Tysabri

Workhuman considers Dublin as venue for major HR conference

Irish-founded software company reports big rise in pretax profit to $32.2m

Irish shares drop as Brexit uncertainty rattles banks

FTSE and European stocks make small advance

Alzheimer’s drug hopes see Biogen shares surge 27%

Pharma group resurrects pipeline therapy it abandoned as ineffective earlier this year

Workhuman reaps $700m rewards of employee recognition

Irish software firm growing fast as organisations see benefit of workplace incentives

YOU MAY ALSO LIKE...
The Irish Times ePaper

North & South

A series examining attitudes North and South about the future of the island

Stardust

Inquests into the nightclub fire that led to the deaths of 48 people